Post-Dialysis Fatigue and Recovery Time in Hemodialysis Patients
Launched by AMASYA UNIVERSITY · May 14, 2024
Trial Information
Current as of February 19, 2025
Active, not recruiting
Keywords
ClinConnect Summary
After obtaining the necessary permissions for the research, informing the patients about the purpose, importance and method of the study by the researcher, and having the volunteer patients read and sign a consent form, the patients were randomly divided into two groups. Randomization of the groups was done in a computer environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those who are 18 years or older,
- • Receiving hemodialysis treatment for at least 3 months,
- • Receiving hemodialysis treatment three times a week,
- • Does not have any open wounds in the area to be applied,
- • No active fistula in the arm to be treated,
- • Does not have a hearing impairment,
- • Sufficient to understand the questions,
- • Open to communication and cooperation,
- • Volunteer and willing for research
- Exclusion Criteria:
- • Having an active oncological problem or receiving oncological treatment,
- • Those with health problems that require contact isolation,
- • The number of dialysis sessions changed during the study,
- • Those who lost their lives while working,
- • Those who had a kidney transplant during the study,
- • Those who want to leave voluntarily at any stage of the study
Trial Officials
Eylem Topbaş, Phd
Study Director
Amasya University
Seyit Ahmet KORKMAZ
Principal Investigator
Amasya University health sciences institute
About Amasya University
Amasya University is a distinguished educational institution in Turkey, renowned for its commitment to advancing research and innovation in the medical and health sciences. The university serves as a clinical trial sponsor, facilitating rigorous scientific studies aimed at evaluating new treatments and interventions. With a focus on fostering collaboration among researchers, healthcare professionals, and industry partners, Amasya University is dedicated to improving patient outcomes and contributing to the global body of medical knowledge. Its state-of-the-art facilities and diverse expertise ensure high-quality clinical research that adheres to ethical standards and regulatory guidelines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amasya, Merkez, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0